Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-99,623
Closed -$3.42M 30
2017
Q4
$3.42M Sell
99,623
-1,501
-1% -$51.2K 2.54% 19
2017
Q3
$3.42M Buy
101,124
+44
+0% +$1.41K 2.43% 21
2017
Q2
$3.22M Sell
101,080
-2,918
-3% -$92K 2.41% 19
2017
Q1
$3.38M Sell
103,998
-4,462
-4% -$141K 2.6% 20
2016
Q4
$3.34M Sell
108,460
-5,551
-5% -$169K 2.63% 21
2016
Q3
$3.66M Sell
114,011
-5,156
-4% -$172K 3.26% 18
2016
Q2
$3.98M Sell
119,167
-10,902
-8% -$348K 3.39% 17
2016
Q1
$3.66M Sell
130,069
-8,869
-6% -$253K 3.13% 18
2015
Q4
$4.25M Sell
138,938
-5,194
-4% -$163K 3.47% 16
2015
Q3
$4.29M Sell
144,132
-32,528
-18% -$1.04M 3.02% 19
2015
Q2
$5.62M Sell
176,660
-5,464
-3% -$178K 3.19% 18
2015
Q1
$6.01M Sell
182,124
-1,925
-1% -$61.2K 3.16% 20
2014
Q4
$5.44M Sell
184,049
-4,410
-2% -$126K 2.68% 21
2014
Q3
$5.29M Buy
188,459
+1,498
+0.8% +$42K 2.71% 20
2014
Q2
$5.26M Buy
186,961
+925
+0.5% +$26.4K 2.51% 20
2014
Q1
$5.67M Buy
186,036
+2,061
+1% +$61.5K 3.34% 16
2013
Q4
$5.35M Sell
183,975
-606
-0.3% -$17.6K 2.91% 18
2013
Q3
$5.03M Sell
184,581
-166
-0.1% -$4.52K 3.09% 18
2013
Q2
$4.91M Buy
+184,747
New +$5.1M 2.86% 20

Other funds holding PFE

ValueWorks's PFE Position: Q1 2018 in Review

ValueWorks sold out of Pfizer (PFE) in Q1 2018, closing a stake of 99,623 shares — an estimated $3.42M sold.

ValueWorks first reported a position in PFE in Q2 2013 and held it in 19 quarters. The position peaked at $6.01M in Q1 2015. 2,229 funds tracked by Wall St. Rank hold PFE as of Q1 2018.

  • ValueWorks reported no remaining Pfizer position as of Q1 2018 after selling out during the quarter.
  • ValueWorks sold 99,623 Pfizer shares in Q1 2018, an estimated $3.42M.
  • ValueWorks first reported a position in Pfizer in Q2 2013 and held it in 19 quarters.
  • ValueWorks's Pfizer position peaked at $6.01M in Q1 2015.
  • 2,229 funds tracked by Wall St. Rank held Pfizer as of Q1 2018.

Based on ValueWorks's 13F filing for Q1 2018, filed 17 May 2018.